Ronald Garren is the author of Biotech Insight, a stock letter for biotechnology investors that provides insightful discussion of competing technologies and future advances. Dr. Garren has been practicing medicine for 30 years, and currently practices hospital-based oncology and consults for biotech companies in the San Francisco Bay area. He is a graduate of Harvard Medical School and completed his residency at New York Hospital. Dr. Garren's experience and expertise enables him to present a valuable perspective to individuals interested in investing in biotech.